Laser showdown: which glaucoma protocol wins?

NCT ID NCT03798223

First seen Jun 26, 2026 · Last updated Jul 31, 2026 · Updated 3 times

Summary

This study compares different ways of performing a laser treatment called selective laser trabeculoplasty (SLT) for people with open-angle glaucoma or high eye pressure. 400 participants will receive SLT using one of several protocols, and researchers will track how much their eye pressure drops over three years. The goal is to find the safest and most effective approach to lower eye pressure and possibly delay the need for eye drops or surgery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Selective laser trabeculoplasty (SLT) with pilocarpine and tetracaine eye drops
What this could lead to
If successful, this could establish a standard, more effective laser procedure to lower eye pressure and reduce the need for daily eye drops in glaucoma patients.
What could go wrong
This is a mid-stage trial comparing different laser techniques, not testing a new drug. The results may show only modest differences between protocols, and long-term effectiveness varies by patient.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GLAUCOMA, OPEN-ANGLE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Ogonkliniken NU-sjukvarden

    Uddevalla, Västra Götaland County, 45153, Sweden

  • Ogonkliniken, Sahlgrenska Universitetssjukhuset

    Mölndal, Västra Götaland County, 43130, Sweden

  • Ogonkliniken, Skaraborgs Sjukhus

    Skövde, Västra Götaland County, 54142, Sweden

  • Ogonkliniken, Sodra Alvsborgs Sjukhus

    Borås, Västra Götaland County, 50182, Sweden

More trials for these conditions

Other studies related to the condition(s) this trial covers.